A randomised double-blinded cross-over trial comparing betamethasone valerate and tacrolimus ointment for the treatment of moderate to severe atopic eczema

ISRCTN ISRCTN27411543
DOI https://doi.org/10.1186/ISRCTN27411543
Protocol serial number N0263128762
Sponsor Department of Health
Funder University College London Hospitals NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
17/04/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr R C H Yu
Scientific

Dermatology Department
The Middlesex Hospital
Mortimer Street
London
W1N 8AA
United Kingdom

Study information

Primary study designInterventional
Study designRandomised double-blinded cross-over trial
Secondary study designRandomised cross over trial
Scientific titleA randomised double-blinded cross-over trial comparing betamethasone valerate and tacrolimus ointment for the treatment of moderate to severe atopic eczema
Study objectivesIs tacrolimus more efficacious than betamethasone valerate ointment in moderate to severe atopic dermatitis?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSkin and Connective Tissue Diseases: Atopic dermatitis
Intervention1. Steroid ointment
2. Other ointment
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Betamethasone valerate and tacrolimus ointment
Primary outcome measure(s)

SCORAD score (numerical assessment score of patient symptoms, range 0-103). Ointment weight. Recording of side-effects noted.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/10/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration100
Key inclusion criteria100 patients from Dermatology
Key exclusion criteriaNot provided at time of registration
Date of first enrolment31/01/2003
Date of final enrolment01/10/2005

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

The Middlesex Hospital
London
W1N 8AA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan